Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
ecohealth_alliance [2022/08/13 15:35] pamela [References] | ecohealth_alliance [2023/05/08 21:16] (current) liam [Link Dump] | ||
---|---|---|---|
Line 46: | Line 46: | ||
=====Connection with Wuhan Institute of Virology===== | =====Connection with Wuhan Institute of Virology===== | ||
- | EcoHealth Alliance Inc funded work by [[:Shi Zheng-Li]] at the [[Wuhan Institute of Virology]] leading to a 2013 paper in Nature which describes the collection and isolation of a SARS-like coronavirus (SL-CoV) named WIV1. This was the first SL-CoV isolated directly from Chinese horseshoe bats (// | + | EcoHealth Alliance Inc funded work by [[:Shi Zheng-Li]] at the [[:Wuhan Institute of Virology]] leading to a 2013 paper in Nature which describes the collection and isolation of a SARS-like coronavirus (SL-CoV) named WIV1. This was the first SL-CoV isolated directly from Chinese horseshoe bats (// |
===EcoHealth Propaganda Science=== | ===EcoHealth Propaganda Science=== | ||
- | In late October, House Republican investigators released details about the National Institutes of Health inadequate oversight of grants that NIH provided to the EcoHealth Alliance. These details arose from a bipartisan “in camera” review of documents conducted at the Department of Health and Human Services (HHS) that was monitored by HHS staff. (For science writers, in camera review means the documents were examined in chambers. In this case, because the NIH refuses to make the documents public.) | + | In late October, House Republican investigators released details about the [[:National Institutes of Health]] inadequate oversight of grants that NIH provided to the EcoHealth Alliance. These details arose from a bipartisan “in camera” review of documents conducted at the Department of [[:Health and Human Services]] (HHS) that was monitored by HHS staff. (For science writers, in camera review means the documents were examined in chambers. In this case, because the NIH refuses to make the documents public.) |
The review((https:// | The review((https:// | ||
Line 65: | Line 65: | ||
===Potential CIA Links=== | ===Potential CIA Links=== | ||
- | //" | + | //" |
// | // | ||
Line 85: | Line 85: | ||
Dr. Karesh has pioneered initiatives focusing attention and resources on solving problems created by the interactions among wildlife, people, and their animals. | Dr. Karesh has pioneered initiatives focusing attention and resources on solving problems created by the interactions among wildlife, people, and their animals. | ||
- | [[: | + | [[: |
- | In January 2008, Aspen announced that former New Jersey governor turned PR executive Christine Todd Whitman; U.S. [[:Centers for Disease Control]] and Prevention director [[:Julie Gerberding]], | + | In January 2008, Aspen announced that former New Jersey governor turned PR executive |
"They join Mark Ganz, president and CEO of Regence [[:Blue Cross Blue Shield]], in leading the new project to help transform health care," stated an Aspen press release.((https:// | "They join Mark Ganz, president and CEO of Regence [[:Blue Cross Blue Shield]], in leading the new project to help transform health care," stated an Aspen press release.((https:// | ||
Line 100: | Line 100: | ||
This [[: | This [[: | ||
- | If anything, the [[:MERS]] study Daszak proposed was even riskier. So he pitched a compromise to the NIH: that if any of the recombined strains showed 10 times greater growth than a natural virus, “we will immediately: | + | If anything, the [[:MERS]] study Daszak proposed was even riskier. So he pitched a compromise to the NIH: that if any of the recombined strains showed 10 times greater growth than a natural virus, “we will immediately: |
This mention of UNC brought a puzzled response from an NIH program officer, who pointed out that the proposal had said the research would be performed at the WIV. “Can you clarify where the work with the chimeric viruses will actually be performed? | This mention of UNC brought a puzzled response from an NIH program officer, who pointed out that the proposal had said the research would be performed at the WIV. “Can you clarify where the work with the chimeric viruses will actually be performed? | ||
Line 112: | Line 112: | ||
Documents Show Texas Researcher Warned Wuhan Lab of COVID Investigation by Congress | Documents Show Texas Researcher Warned Wuhan Lab of COVID Investigation by Congress | ||
- | Judicial Watch announced today that it obtained 412 pages of new records that show the former director of the Galveston National Laboratory at the University of Texas Medical Branch (UTMB), Dr. James W. Le Duc warned Chinese researchers at the Wuhan Institute of Virology of potential investigations into the covid issue by Congress. | + | Judicial Watch announced today that it obtained 412 pages of new records that show the former director of the [[:Galveston National Laboratory]] at the University of Texas Medical Branch (UTMB), Dr. James W. Le Duc warned Chinese researchers at the Wuhan Institute of Virology of potential investigations into the covid issue by Congress. |
Additionally, | Additionally, | ||
Line 120: | Line 120: | ||
A February 9, 2020, email from Le Duc prepares Zhiming with questions that may arise in an investigation of the origins of the COVID-19 virus. Le Duc warns that questions about the virus originating from the Wuhan Institute of Virology initially came only from social media, but had recently expanded to “alternate information sources,” “senior officials” and “reputable newspapers” all linking the opening of the ABSL 4 facility at the as the source of the virus outbreak. | A February 9, 2020, email from Le Duc prepares Zhiming with questions that may arise in an investigation of the origins of the COVID-19 virus. Le Duc warns that questions about the virus originating from the Wuhan Institute of Virology initially came only from social media, but had recently expanded to “alternate information sources,” “senior officials” and “reputable newspapers” all linking the opening of the ABSL 4 facility at the as the source of the virus outbreak. | ||
- | In an email dated May 6, 2019, Le Duc thanks the National Institutes of Allergy and Infectious Diseases | + | In an email dated May 6, 2019, Le Duc thanks the National Institutes of Allergy and Infectious Diseases |
Le Duc informs Bernabe about a proposal to begin work in Wuhan later in the year. | Le Duc informs Bernabe about a proposal to begin work in Wuhan later in the year. | ||
Line 128: | Line 128: | ||
Le Duc informs Zhiming that his paper was “nicely written” concerning biocontainment labs in China, however, the paper should be expanded “to let readers know that security is an important aspect of your program.” | Le Duc informs Zhiming that his paper was “nicely written” concerning biocontainment labs in China, however, the paper should be expanded “to let readers know that security is an important aspect of your program.” | ||
- | In an email dated January 16, 2020, Le Duc congratulates Dr. George F. Gao, director-general of the Chinese Center for Disease Control and Prevention (China CDC), on his leadership and China’s response to COVID-19. Le Duc includes two articles of interest and further states: | + | In an email dated January 16, 2020, Le Duc congratulates Dr. [[:George F. Gao]], director-general of the Chinese Center for Disease Control and Prevention (China CDC), on his leadership and China’s response to COVID-19. Le Duc includes two articles of interest and further states: |
As you might expect, we are following the evolving story on nCoV from Wuhan very closely and we are eager to get an isolate for antiviral testing. Dr Tseng’s [https:// | As you might expect, we are following the evolving story on nCoV from Wuhan very closely and we are eager to get an isolate for antiviral testing. Dr Tseng’s [https:// | ||
Line 145: | Line 145: | ||
Le Duc informs Zhiming that the U.S. was at the start of the “explosion of cases in our region and over the next few weeks we would see very high numbers of cases requiring hospitalizations and ICU support,” and suggests that “it would be excellent if we could identify areas for collaborations.” | Le Duc informs Zhiming that the U.S. was at the start of the “explosion of cases in our region and over the next few weeks we would see very high numbers of cases requiring hospitalizations and ICU support,” and suggests that “it would be excellent if we could identify areas for collaborations.” | ||
- | In an April 29, 2020, email, NIAID Associate Director for International Research Affairs Gray Handley informs Le Duc of an inquiry from U.S. Embassy in Beijing, “asking what was the official name of your DoD supported training program and some other background information.,,, | + | In an April 29, 2020, email, |
To the question: “Did this training take place in the U.S., China, or in both countries? | To the question: “Did this training take place in the U.S., China, or in both countries? | ||
Line 168: | Line 168: | ||
{{ :: | {{ :: | ||
- | ===== Link Dump ===== | ||
+ | ==== Risk-Zoonotic-Virus-Hotspots-Grant-Notice ==== | ||
+ | ((https:// | ||
+ | {{ :: | ||
+ | ===== Link Dump ===== | ||
+ | * [[https:// |